N~1~,N~2~,2-trimethylalaninamide hydrochloride, 95.0%, 10g

3-Bromo-6-chloroimidazo[1,2-a]pyrimidine, 95.0%, 250mg

5-Bromo-3-(diethoxymethyl)-1H-pyrazolo[3,4-c]pyridine, 97%, 250mg

2'-Bromo-4-methyl-4'-(trifluoromethoxy)-1,1'-biphenyl, 98%, 500mg

Colonna capillare per GC ROTI®Cap-1701, 25 m, 0,32 mm, 0,35 µm, 1 Pezzo(i)

5-Fluoro-2-methylthiophenol, 97.0%, 1g

3-(4-chlorophenyl)-4-[(furan-2-yl)methyl]-4,5-dihydro-1H-1,2,4-triazole-5-thione, 97%, 250mg

1-(5-Chloro-2-hydroxy-3-methylphenyl)ethan-1-one, 97%, 1g

(S)-3-methyl-2-phenylbutan-1-amine, 98%, 1g

3-Bromo-7-methyl-1H-pyrrolo[2,3-c]pyridine, 98+%, 5g

(1E)-1-tert-Butoxy-1-(trimethylsilyloxy)propene>92.0%(GC)1g

2-Chloro-5-methyl-4-(trifluoromethyl)pyridine, 98%, 100mg

2,4-Difluoro-6-hydrazinylpyridine, 97%, 250mg